CD8A and neoplasm: The date shows that immunisation of BALB/c mice with tumour lysate pulsed DC together with oral gavage of 1 mg TRF (DC+TL+TRF group) daily can increase the numbers of NK cells and CD8+ T-cells, which could in turn lead to enhancement of the cell-mediated arm of the immune system that is crucial to fight tumours.